a new drug for hypertension, Micardis (telmisartan)

Boehringer Ingelheim and Glaxo are co-marketing a new drug for hypertension, Micardis (telmisartan).

It's the 5th angiotensin II receptor blocker...joining Cozaar (losartan), Diovan (valsartan), Avapro (irbesartan), and Atacand (candesartan).

A 6th one, Teveten (eprosartan, Solvay), will be out soon.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote